318 related articles for article (PubMed ID: 29524132)
61. A Review on CRISPR-mediated Epigenome Editing: A Future Directive for Therapeutic Management of Cancer.
Chakravarti R; Lenka SK; Gautam A; Singh R; Ravichandiran V; Roy S; Ghosh D
Curr Drug Targets; 2022; 23(8):836-853. PubMed ID: 35078394
[TBL] [Abstract][Full Text] [Related]
62. Delivery of Designer Epigenome Modifiers into Primary Human T Cells.
Mlambo T; Romito M; Cornu TI; Mussolino C
Methods Mol Biol; 2018; 1767():189-203. PubMed ID: 29524135
[TBL] [Abstract][Full Text] [Related]
63. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
[TBL] [Abstract][Full Text] [Related]
64. Reversing Mechanoinductive DSP Expression by CRISPR/dCas9-mediated Epigenome Editing.
Qu J; Zhu L; Zhou Z; Chen P; Liu S; Locy ML; Thannickal VJ; Zhou Y
Am J Respir Crit Care Med; 2018 Sep; 198(5):599-609. PubMed ID: 29924937
[TBL] [Abstract][Full Text] [Related]
65. Precise epigenomic editing with a SunTag-based modular epigenetic toolkit.
Guhathakurta S; Adams L; Jeong I; Sivakumar A; Cha M; Bernardo Fiadeiro M; Hu HN; Kim YS
Epigenetics; 2022 Dec; 17(13):2075-2081. PubMed ID: 35920441
[TBL] [Abstract][Full Text] [Related]
66. Novel Approaches to Epigenetic Therapies: From Drug Combinations to Epigenetic Editing.
Majchrzak-Celińska A; Warych A; Szoszkiewicz M
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33572577
[TBL] [Abstract][Full Text] [Related]
67. Development of Toolboxes for Precision Genome/Epigenome Editing and Imaging of Epigenetics.
Nomura W
Chem Rec; 2018 Dec; 18(12):1717-1726. PubMed ID: 30066981
[TBL] [Abstract][Full Text] [Related]
68. Harnessing the native type I-B CRISPR-Cas for genome editing in a polyploid archaeon.
Cheng F; Gong L; Zhao D; Yang H; Zhou J; Li M; Xiang H
J Genet Genomics; 2017 Nov; 44(11):541-548. PubMed ID: 29169919
[TBL] [Abstract][Full Text] [Related]
69. Beyond Native Cas9: Manipulating Genomic Information and Function.
Mitsunobu H; Teramoto J; Nishida K; Kondo A
Trends Biotechnol; 2017 Oct; 35(10):983-996. PubMed ID: 28739220
[TBL] [Abstract][Full Text] [Related]
70. Epigenome editing strategies for the functional annotation of CTCF insulators.
Tarjan DR; Flavahan WA; Bernstein BE
Nat Commun; 2019 Sep; 10(1):4258. PubMed ID: 31534142
[TBL] [Abstract][Full Text] [Related]
71. Targeting epigenetic aberrations of sarcoma in CRISPR era.
Tanaka M; Nakamura T
Genes Chromosomes Cancer; 2023 Sep; 62(9):510-525. PubMed ID: 36967299
[TBL] [Abstract][Full Text] [Related]
72. Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system.
Garcia-Bloj B; Moses C; Sgro A; Plani-Lam J; Arooj M; Duffy C; Thiruvengadam S; Sorolla A; Rashwan R; Mancera RL; Leisewitz A; Swift-Scanlan T; Corvalan AH; Blancafort P
Oncotarget; 2016 Sep; 7(37):60535-60554. PubMed ID: 27528034
[TBL] [Abstract][Full Text] [Related]
73. Epigenome editing: targeted manipulation of epigenetic modifications in plants.
Shin H; Choi WL; Lim JY; Huh JH
Genes Genomics; 2022 Mar; 44(3):307-315. PubMed ID: 35000141
[TBL] [Abstract][Full Text] [Related]
74. Chemically Controlled Epigenome Editing through an Inducible dCas9 System.
Chen T; Gao D; Zhang R; Zeng G; Yan H; Lim E; Liang FS
J Am Chem Soc; 2017 Aug; 139(33):11337-11340. PubMed ID: 28787145
[TBL] [Abstract][Full Text] [Related]
75. Targeted activation of diverse CRISPR-Cas systems for mammalian genome editing via proximal CRISPR targeting.
Chen F; Ding X; Feng Y; Seebeck T; Jiang Y; Davis GD
Nat Commun; 2017 Apr; 8():14958. PubMed ID: 28387220
[TBL] [Abstract][Full Text] [Related]
76. Genome and Epigenome Editing in Mechanistic Studies of Human Aging and Aging-Related Disease.
Lau CH; Suh Y
Gerontology; 2017; 63(2):103-117. PubMed ID: 27974723
[TBL] [Abstract][Full Text] [Related]
77. The Impact of Chromatin Dynamics on Cas9-Mediated Genome Editing in Human Cells.
Daer RM; Cutts JP; Brafman DA; Haynes KA
ACS Synth Biol; 2017 Mar; 6(3):428-438. PubMed ID: 27783893
[TBL] [Abstract][Full Text] [Related]
78. Web-based design and analysis tools for CRISPR base editing.
Hwang GH; Park J; Lim K; Kim S; Yu J; Yu E; Kim ST; Eils R; Kim JS; Bae S
BMC Bioinformatics; 2018 Dec; 19(1):542. PubMed ID: 30587106
[TBL] [Abstract][Full Text] [Related]
79. Current therapies for osteoarthritis and prospects of CRISPR-based genome, epigenome, and RNA editing in osteoarthritis treatment.
Chen Y; Luo X; Kang R; Cui K; Ou J; Zhang X; Liang P
J Genet Genomics; 2024 Feb; 51(2):159-183. PubMed ID: 37516348
[TBL] [Abstract][Full Text] [Related]
80. Transgenerationally Transmitted DNA Demethylation of a Spontaneous Epialleles Using CRISPR/dCas9-TET1cd Targeted Epigenetic Editing in Arabidopsis.
Wang M; He L; Chen B; Wang Y; Wang L; Zhou W; Zhang T; Cao L; Zhang P; Xie L; Zhang Q
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
